HomeNewsIndiaState governments urge Centre to procure COVID-19 vaccines for all as Moderna, Pfizer refuse to deal with states

State governments urge Centre to procure COVID-19 vaccines for all as Moderna, Pfizer refuse to deal with states

Pharma giants Moderna and Pfizer have refused vaccine deals with Delhi and Punjab, insisting they would only have direct sale agreements with the Government of India.

May 25, 2021 / 13:33 IST
Story continues below Advertisement
Delhi Chief Minister Arvind Kejriwal informed that US pharmaceutical giants Pfizer and Moderna have declined to sell coronavirus vaccines to the city government as they want to directly deal with the Centre. (Representative image)
Delhi Chief Minister Arvind Kejriwal informed that US pharmaceutical giants Pfizer and Moderna have declined to sell coronavirus vaccines to the city government as they want to directly deal with the Centre. (Representative image)

After two American COVID-19 vaccine manufacturers said that they wanted to directly deal with the Centre, state governments are now demanding the union government to import and distribute vaccines to all states.

Pharma giants Moderna and Pfizer have refused vaccine deals with Delhi and Punjab, insisting they would only have direct sale agreements with the Government of India.

Story continues below Advertisement

Delhi Chief Minister Arvind Kejriwal informed that US pharmaceutical giants Pfizer and Moderna have declined to sell coronavirus vaccines to the city government as they want to directly deal with the Centre.

"We have had talks with Pfizer and Moderna. They said they won't give us vaccine and will directly talk to the Centre," Kejriwal told reporters on May 24.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show